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INTRODUCTION
I
MAGE-BASED SCREENING IS BECOMING INCREASINGLY WIDE-
SPREAD and productive in both commercial and academic 
research environments, at both primary and secondary screening 
phases. It is being used for a wide variety of scientific objectives 
such as drug discovery, chemical probe discovery, and functional 
genomics using RNA interference-treated samples.
1-4 Biologists 
have long depended on microscopy-based assays to study the 
mechanisms of biological processes, and the demand to move 
new image-based assays from low throughput to high throughput 
is growing substantially.
Most  image-based  high-throughput  screening  assays  are 
currently  analyzed  using  commercial  instrumentation  with 
bundled software, usually designed to score assays of particular 
pharmaceutical interest. In general, these assays are designed   
to produce a single numerical output per well. This approach 
simplifies the process of screening for the end user and stream-
lines high-content screening (HCS) so that it can approach the 
speed of traditional high-throughput assays. This strategy of 
simplification allows high-throughput screening (HTS) experts 
familiar with other screening modalities to transfer their knowl-
edge to HCS.
Developing  approaches  to  quantify  novel  assays  using 
image  analysis  often  remains  a  time-consuming  challenge. 
Although developing a routine for a new assay is not always 
straightforward, several options exist: (1) write and test raw 
image analysis code from scratch, but this is time-consuming 
and requires a programmer with expertise in image analysis; 
(2) adapt existing assay-specific software; (3) force existing 
software to output additional measures of interest and explore 
those measures, but this sometimes requires processing images 
through several different assay-specific routines and combining 
the measurements; and (4) test multiple software packages, but 
this is rarely feasible due to the costs and the amount of time 
required to optimize each software package for the assay. In 
addition, proprietary software usually conceals the underlying 
algorithms so that when differences occur between software 
packages, it is unclear whether the algorithms themselves or 
slight differences in settings yielded the observed differences. 
Thus, the current approach to image-based assay development 
requires significant time, expertise, and/or expense to adapt to 
a novel assay.
An alternative to these approaches is to use machine learn-
ing to score images of individual cells or cell populations based 
on a combination of multiple features extracted from the cells. 
Although machine-learning approaches are not yet widespread 
for HCS, they have been shown useful for discerning complex 
phenotypes in many cases,
5-11 and we are successfully using it 
for roughly half of the screens in our laboratory.
12 There are 
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some  situations,  however,  in  which  a  machine-learning 
approach  is  not  suited  for  an  assay.  First,  machine-learning 
algorithms must often be trained separately for each experi-
mental batch to perform well; in some unfortunate cases, vari-
ations may be significant enough as to require separate training 
for each plate. This can be quite time-consuming as compared 
to normalizing a single feature across batches or setting thresh-
olds for a single feature for each batch. Aside from this practi-
cal concern, a machine-learning approach may be scientifically 
undesirable: positive controls used to train the algorithm may 
exhibit  more  than  just  the  perturbation  of  interest;  conse-
quently, the cells may also display other morphological changes 
that are not relevant to the biological process being studied. In 
contrast,  scoring  the  assay  using  a  single  feature  of  known 
biological relevance affords the researcher more control over 
the phenotype to be scored. Thus, even though machine learn-
ing may score a phenotype more accurately in many cases, 
there are situations in which scoring the assay with a single, 
well-understood feature is preferable.
Here, we describe a screening approach that can improve 
image assay development when scoring assays based on a sin-
gle feature.
MATERIALS AND METHODS
Images used in this work are publicly available and were 
graciously compiled by Ilya Ravkin (http://www.ravkin.net/
SBS/Image-Library.htm). There are 4 image sets, 2 for the 
Transfluor assay (called CompuCyte and Roche) and 2 for 
the cytoplasm-to-nucleus assay (called BioImage and Vitra). 
These images are also freely available at the Broad Bioimage 
Benchmark  Collection  (http://www.broadinstitute.org/
bbbc).
The  open-source  cell  image  analysis  software  used  here, 
CellProfiler, is freely available at http://www.cellprofiler.org.
13 
An image analysis pipeline (a serial set of image analysis algo-
rithms)  was  constructed  for  each  assay  in  version  2.0  of 
CellProfiler.  This  standard  pipeline  (Fig.  1B)  was  adjusted 
appropriately for each image set to load the images and meta-
data  (e.g.,  plate-well  identification  and  sample  metadata, 
including compound, dose and positive/negative control status, 
and cell type), segment regions of interest, measure features, 
and export the resulting data. To correct for persistent illumina-
tion variations across all images (due to many possible sources, 
including optical hardware irregularities, illumination patterns, 
or shading), we performed illumination correction with a sepa-
rate short CellProfiler pipeline. In brief, all images for each 
individual channel are summed, and then the resultant image is 
smoothed with a large median filter (~150 × 150 pixels) to 
construct illumination functions. This illumination function is 
then used by the main analysis pipeline: each raw image is 
divided by the illumination function before subsequent process-
ing. Tutorials for creating and modifying CellProfiler pipelines 
are available online and in print,
14,15 and the pipelines used in 
this study are freely available at the Broad Bioimage Benchmark 
Collection (http://www.broadinstitute.org/bbbc).
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FIG. 1.  Image assays and image analysis pipeline design. (A) Two representative images from each of the 4 image sets are shown: 1 positive 
and 1 negative control. Each has a red or blue channel (DNA stain) and a green channel (labeling the molecule of interest). (B) A schematic 
pipeline, displaying typical steps of the image analysis pipeline.Logan and Carpenter
842    www.sbsonline.org  Journal of Biomolecular Screening 15(7); 2010
Image processing was conducted on a single node of the 
Broad computing cluster with these specifications: 64-bit AMD 
processor,  SUSE  Linux  V10.1,  Quad-Core  AMD  Opteron 
Processor 8356 at 2.3 GHz, 512 KB L2 cache, and 16 GB RAM. 
Note, however, that processing times on an Apple MacBook Pro 
with a 2.5-GHz processor and 4-GB 667-MHz RAM were typi-
cally within a factor of 1.5 of the cluster machine.
RESULTS
In our own laboratory, when a machine learning approach is 
not appropriate, we have typically scored image-based cellular 
assays using the design approach, using image analysis exper-
tise to select or create a feature to be measured by our open-
source  high-throughput  cell  image  analysis  software, 
CellProfiler.
16-26 In our experience, designing measurements to 
suit a particular new assay is fruitful. Still, we hypothesized 
that, like screening versus design approaches to identify drug 
leads, a screening approach to choose image-based assay fea-
tures might be less time, resource, and expertise consuming in 
at least some situations. We set out to develop and test this 
approach.
Experienced screeners are well aware that the success of any 
screening approach is determined both by the design of the 
assay  and  by  the  quality  of  the  library  being  screened. 
Correspondingly, screening to find an optimal measured fea-
ture to use for scoring a particular high-content assay is highly 
dependent on having a good library of features. This library 
must  contain  features  that  adequately  represent  the  cellular 
morphology of interest in the assay. Flexible, modular software 
is needed for this purpose; CellProfiler meets these criteria by 
offering the use of numerous algorithms and optional settings, 
and it measures a large number of features, including the size 
and shape of each cell and subcellular compartment, as well as 
the intensity and texture of each stain within each cell and sub-
cellular  compartment.
27  For  a  typical  assay,  this  can  yield 
roughly 500 to 1000 measured features per cell.
Although we call this method a “screening” approach, in 
reality, we do not screen an identical library of assay features 
for every new assay. Rather, we typically add several poten-
tially useful, designed features to the library for each given 
assay. This strategy is analogous, in the screening world, to 
adding a sublibrary of chemical compounds thought to be more 
specific to the target class of interest, in addition to screening a 
large, diverse chemical library. The following exemplifies this 
principle.  The  standard  image  analysis  pipeline  records  the 
mean and median of each measured cellular feature for all cells 
in an image. However, for some assays, the mean or median of 
per cell measurements is not the most useful metric. Rather, 
other  features  derived  from  the  raw  per  cell  measurements 
(called “derived features”) can be quite powerful. Derived fea-
tures take advantage of individual cell data and include calcula-
tions such as ratios of features or the percentage of cells above 
a threshold. The framework of CellProfiler allows the researcher 
to use his or her intuition and knowledge to easily derive fea-
tures and add them to the feature library, without computer 
programming. This process involves, for example, choosing 
which features to ratio or which threshold to apply to a feature. 
Currently, derived features can be added one by one to the fea-
ture library to be screened in CellProfiler using modules such 
as Calculate Math and Classify Objects. It is feasible to extend 
CellProfiler to record hundreds of thousands of features, for 
example, to count the percentage of cells in each sample above 
a particular threshold for every measured feature or to calculate 
a huge variety of ratios of features. This would add to the fea-
ture library but also would affect the rate of false-positive fea-
tures scored as relevant to the assay, in addition to requiring 
more intense computing resources. Human intuition is there-
fore still highly valuable in choosing what features to include 
in  the  library  so  as  to  minimize  the  chances  of  overfitting   
the available data and/or generating false positives, as we dis-
cuss later.
For this experiment, we configured CellProfiler to identify 
and measure cells and subcellular compartments and added the 
Calculate Statistics module to the image-processing pipeline to 
calculate various measures of assay performance, which will be 
used as the basis for selecting a feature for the assay. These 
assay performance measures currently include the Z′ factor and 
the V factor. The Z′ factor indicates how well separated the 
positive and negative controls are, given the variation present 
in both populations.
28 The V factor, by contrast, capitalizes on 
all the data along a dose-response curve rather than just the 
positive and negative controls alone. It is especially appropriate 
for image-based assays because it measures the variability of 
intermediate responses to the assay, thus avoiding the possibil-
ity that the image analysis algorithms have been tuned to pro-
duce saturated results for just positive and negative controls.
29 
For both Z′ and V factors, the highest possible value (best assay 
quality) is 1, and they can range into negative values (for assays 
in which distinguishing between positive and negative controls 
is difficult or impossible). A Z′ factor >0 is potentially screen-
able; a Z′ factor >0.5 is considered an excellent assay.
We  began  by  testing  this  approach  on  the  cytoplasm-to-
nucleus translocation (CNT) assay using the 2 publicly available 
image sets, BioImage and Vitra (Fig. 1A, top). In these assays, 
the relative distribution of fluorescence intensities between the 
cytoplasm and the nucleus of a cell changes under certain con-
ditions. We measured this change by first correcting for illumina-
tion variations consistent across the image set in each channel 
(Fig.  1B).  Using  the  DNA  stain,  we  readily  segmented  the 
nuclei from the background. There is no separate stain to iden-
tify  the  cell  boundary,  so  we  identified  2  compartments  of 
potential utility for the assay: (1) the region defined by the 
boundaries of the green fluorescence signal and (2) a compart-
ment defined by dilating each nucleus a defined amount. We 
then took numerous measurements, including intensities, sizes, Screening Cellular Feature Measurements for Image-Based Assay Development
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FIG. 2.  Cytoplasm-to-nucleus translocation (CNT) assay quality statistics. (A, left) Bar plots display Z′ factors for each feature, grouped by 
feature category and ordered by descending Z′ factor values within each category. Values below –10 are not displayed, and note that the maximum 
possible Z′ factor is 1. Feature categories begin at their x-axis label and progress to the right. BioImage LY294002 and Vitra MCF7 plots are not 
shown, as they are qualitatively similar to the respective plots shown. (A, right) The same data are plotted, but values below 0 are not shown, 
highlighting features that are potentially screenable. The 2 CNT data sets display similar screenable features, and V factors also display qualita-
tively the same pattern (not shown). Note that the number of intensity measures are greater in BioImage than in Vitra because the propagate 
algorithm was not reliable at detecting the cytoplasm in Vitra positive control images and thus not screened. (B) The top-scoring feature, in 
terms of Z′ and V factor, is shown for each CNT image set. BioImage has 2 drugs, wortmannin and LY294002, and Vitra has 2 cell types, A549 
and MCF7.
shapes, correlations between channels, radial distributions, and 
textures within each compartment, for each cell or across the 
entire image. For some features, we calculated ratios for each 
cell (e.g., intensity in the nucleus compartment vs. the dilated 
nucleus  compartment),  and  for  some  features,  we  classified 
cells into categories above or below a few threshold values 
chosen by examining the values of features for particular sam-
ples using the Show Data on Image tool.
For  each  measurement,  the  pipeline  calculated  statistical 
assay quality metrics, the Z′ and V factors, and we categorized 
these according to measurement category (Fig. 2, top). For the 
CNT assays, the highest Z′ and V factor categories (Fig. 2B) 
include the ratio between the mean intensities of the cytoplasm 
and  nucleus  compartments  (Ratio),  especially  when  thresh-
olded at the per cell level (Classified Ratio), and all indicate 
that  they  are  screenable  assays  (>0.5). These  measurements 
were expected to be valuable and were in fact designed to suit 
the assay; thus, in this case, the value of the screening approach 
was in the ability to test several possible thresholds and dila-
tion factors in the pipeline in parallel, speeding the identifica-
tion of the most appropriate one for each particular image set. 
Still, it is worth noting that other measures such as Correlation 
(correlation  of  green  and  blue  pixels),  Radial  Distribution 
(green pixel intensity distribution along a radius from cell cen-
troid to dilated nucleus), and Texture (a spatial variance meas-
ure) are also effective readouts for this assay (Fig. 2, top right). Logan and Carpenter
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Choosing one of these alternative measurements might be pref-
erable in some cases. For example, several of these are less 
parameter dependent than the Classified Ratio feature (which 
required “tweaking” by setting a proper threshold that changes 
from experiment to experiment).
We next analyzed the Transfluor assay, in which positive 
controls result in a speckled phenotype (Fig. 1A, bottom). We 
used pipelines similar to those for the CNT assay to extract 
measurements for the 2 Transfluor image sets, CompuCyte and 
Roche. We added some algorithms tailored for speckle identi-
fication to the pipeline, including the use of a top-hat filter in 
the  Enhance  or  Suppress  Features  module  and  per  object 
thresholding within Identify Primary Objects. The best catego-
ries  for  the  Transfluor  assays  were  mostly  similar  between 
them, although different from the CNT features. High-scoring 
features included Speckle Count (number of small, bright green 
spots per image), Speckle Per Parent (number of speckles per 
parent  cell),  Texture  (CompuCyte),  and  Radial  Distribution 
(Roche) (Fig. 3A). The top scoring V factors for each Transfluor 
set indicate that they are highly screenable (>0.5), although the 
Roche Z′ factor is slightly below this threshold (Fig. 3B). The 
top-scoring  features  encompassed  a  broad  range,  including 
speckle texture, integrated edge intensity of green speckles, and 
the coefficient of variation of intensity along a radial axis from 
center to cell membrane.
These results indicate that the screening approach is helpful for 
identifying those features that may be suited to score a particular 
assay in cases where machine learning is not preferred. There are 
a few cautionary notes about the approach to mention. First, select-
ing the best measure from a large library of measures can uncover 
spurious differences between positive and negative controls, par-
ticularly when only a small number of positive and negative con-
trols are available. Therefore, the statistically sound approach is to 
select a feature based on one set of control samples (the “training 
set”) and then test whether that feature is also effective for scoring 
a  separate  set  of  control  samples  (the  “test  set”).  Taking  this 
approach with control samples prepared in different experimental 
batches is also good practice, to confirm both the statistical value 
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of the selected image-based feature while simultaneously confirm-
ing biological reproducibility. The second danger of the screening 
approach  for  assay  development  feature  selection  is  a  hazard 
shared in common with machine-learning methods, as described 
in the Introduction. Features may be very effective for distinguish-
ing a particular positive control from negative controls based on 
morphological properties that are not the primary goal of the assay. 
Take, for example, a cytoplasm-to-nucleus assay where the posi-
tive control induces translocation but also happens to reduce the 
growth rate of the cells. Cells would be less crowded in positive 
control images as compared to negative control images; care must 
be taken to avoid selecting the readout of the assay to be a feature 
that is simply a measure of cell sparseness rather than the true 
phenotype of interest. Some such features could be spuriously 
reading out phenotypes that are not of direct interest; for example, 
in some cell types, the intensity of a cytoskeletal stain at the edge 
of the cell will be higher if the cell touches another cell, yielding a 
perhaps surprising indirect measure of cell sparseness. Human 
intuition and an understanding of image analysis algorithms are 
often necessary to interpret whether a particular feature is measur-
ing the true phenotype of interest. It is also helpful to use several 
positive control conditions that share the primary phenotype of 
interest but vary in other features of the cells, if such controls are 
available.
If processing speed is a concern, the methods described here 
can be used for assay development, and then the pipeline can be 
“dumbed down” to eliminate calculation of unnecessary measure-
ments when running the assay in HTS mode. For some environ-
ments, streamlining the analysis may be helpful, but in practice, 
we rarely do this because we typically conduct extensive second-
ary analyses of the primary screening data to categorize hit sam-
ples by features other than the primary readout, thus harvesting as 
much information content from the primary screen as possible.
Here, we have demonstrated the usefulness of the screening 
approach to image-based assay development, whereby the best 
cellular feature for an assay is chosen quantitatively from a 
library of hundreds of candidate measurements. The concept is 
simple, and the methods built into CellProfiler make such an 
analysis  straightforward,  even  for  researchers  without    pro-
gramming skills. All of the algorithms and software presented 
are open source and freely available. We presented results from 
the 4 publicly available image sets, the best published assay 
quality  results  to  our  knowledge.  We  are  eager  for  other 
researchers to continue to advance the algorithms in this field 
by besting our results, publishing them, and ideally making 
open-source algorithms available for the screening community.
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